Stephen Chanock, M.D.
Acting Director
Advanced Technology Center
National Cancer Institute
National Institutes of Health
Gaithersburg, Maryland
www.nci.nih.gov

Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed training in pediatrics, infectious diseases, and pediatric hematology/oncology at Children’s Hospital in Boston and the Dana-Farber Cancer Institute.

Currently, Dr. Chanock is the Acting Director of the NCI Core Genotyping Facility (CGF), located at the Advanced Technology Center. He joined NCI in 1991, where he has been investigating the molecular, cellular, and clinical problems of infectious complications in patients with cancer and HIV infection. He also holds an appointment as a senior investigator in the Pediatric Oncology Branch of NCI’s Center for Cancer Research.